XBiotech (XBIT) Total Non-Current Liabilities (2015 - 2026)
XBiotech (XBIT) posted Total Non-Current Liabilities of $3.36 million for Q2 2026, down 12.9% from $3.86 million a year earlier.
Powered by 
Analysis
XBiotech (XBIT) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends
At the end of FY2025, XBiotech's Total Non-Current Liabilities came in at $7.93 million, down 47.5% from FY2024.
- Annual Total Non-Current Liabilities shows a five-year compound annual growth rate of 14.8% (FY2020 to FY2025).
- In prior years, XBiotech's Total Non-Current Liabilities was $15.11 million in FY2024 (+147.6%), $6.1 million in FY2023 (+47.9%), $4.13 million in FY2022 (-4.6%) and $4.33 million in FY2021 (+8.6%).
- The Q2 2026 figure stands as the lowest quarterly Total Non-Current Liabilities since Q1 2021.
- On a year-over-year basis, Total Non-Current Liabilities increased in two of the last seven quarters, with growth averaging 9.4%.
- The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q1 2024, with growth of 366.7%; the weakest was Q3 2025, with a decline of 77.7%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,209.53 Bn | 1,178.12 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 625.18 Bn | 543.70 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 510.63 Bn | 483.79 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 365.88 Bn | 320.31 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 293.11 Bn | 257.51 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.69 Bn | 235.45 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 237.29 Bn | 192.69 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 194.23 Bn | 168.34 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 171.73 Bn | 118.68 Bn | 10.94 Bn | 97.04 Bn |
| 10 | XBiotech | 61.59 Mn | -473.83 Mn | - | 3.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.36 Mn |
| Dec 31, 2025 | 7.93 Mn |
| Sep 30, 2025 | 3.57 Mn |
| Jun 30, 2025 | 3.86 Mn |
| Mar 31, 2025 | 5.41 Mn |
| Dec 31, 2024 | 15.11 Mn |
| Sep 30, 2024 | 15.99 Mn |
| Jun 30, 2024 | 17.14 Mn |
| Mar 31, 2024 | 16.88 Mn |
| Dec 31, 2023 | 6.10 Mn |
| Sep 30, 2023 | 5.29 Mn |
| Jun 30, 2023 | 4.45 Mn |
| Mar 31, 2023 | 3.62 Mn |
| Dec 31, 2022 | 4.13 Mn |
| Sep 30, 2022 | 4.45 Mn |
| Jun 30, 2022 | 9.11 Mn |
| Mar 31, 2022 | 3.76 Mn |
| Dec 31, 2021 | 4.33 Mn |
| Sep 30, 2021 | 3.97 Mn |
| Jun 30, 2021 | 4.00 Mn |
API Access
XBiotech Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=XBIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "XBIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=XBIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();